First, the effect is enzymatic and cumulative you are shifting a metabolic set-point over days and weeks, not triggering an acute hormonal event, which is why steady daily exposure matters more than any single large dose
5-Amino-1MQ inhibits NNMT (nicotinamide N-methyltransferase), an enzyme that depletes NAD+ and promotes fat storageraising NAD+ increases mitochondrial respiration and thermogenesis
Second, lipogenesis decreases, meaning less dietary energy gets converted to stored fat
Every fat-metabolism, NAD+, SIRT1 and lean-mass effect described above is preclinical (rodent or cell) only and should be read as a hypothesis, not an established human benefit
References Nature Medicine (2014) Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity PMC (2024) Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunctions Frontiers in Pharmacology (2024) NNMT: a novel therapeutic target for metabolic syndrome Creative Peptides Peptide stability and storage guidelines for lyophilized compounds PubMed (2021) LC-MS/MS assay for 5-amino-1-methylquinolinium: pharmacokinetic and oral bioavailability study PMC Subcutaneous drug injection review: pharmacologic considerations NCBI Bookshelf Best practices for injection (asepsis, preparation, and administration) ResearchGate (2021) Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice PMC (2022) Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports / NMN.com Role of NNMT inhibition in muscle strength: enhanced grip strength with exercise Swolverine 5-Amino-1MQ mechanism, benefits, stacking and cycling guide CDC Vaccine administration: subcutaneous route (angle/site
In diet-induced obese (DIO) mouse models, NNMT inhibition with 5-Amino-1MQ was associated with reduced white adipose tissue mass without affecting food intake, suggesting changes in energy expenditure rather than appetite suppression
